ClearEdge3D has announced the availability of EdgeWise Plant, an as-built modeling platform that reduces potential errors associated with manual modeling techniques. The platform serves as an ...
A piping system in AVEVA E3D Design automatically modeled in EdgeWise Plant A piping system modeled in EdgeWise Plant and exported to Autodesk Plant 3D An industrial as-built model in AVEVA E3D Design ...
Edgewise Therapeutics , Inc. (NASDAQ:EWTX), with a market capitalization of $2.67 billion, is a biopharmaceutical company focused on developing innovative therapies for severe, rare muscle disorders.
Edgewise: Stock Is Bouncing On Heart Disease Drug Data, Albeit From Just 7 Patients (Rating Upgrade)
I previously rated Edgewise Therapeutics a sell due to limited market potential and lack of clinical data for sevasemten. Sevasemten, Edgewise's lead drug, remains unchanged in its potential, with ...
Edgewise Therapeutics, Inc. reported its first quarter earnings, revealing a strong cash position of $532m and a net loss of $(28.5m). The company is advancing two clinical-stage programs, including a ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback